Excited to see the results
You have completed the minimum four weeks at your current dose
Pictured: Sign at Pfizers headquarters in New York/iStock, JHVEPhoto Pfizer on Friday said it is scrapping an investigational twice-daily oral Glucagon-like peptide-1 receptor agonist candidate after topline data from a Phase IIb trial of obese patients without type 2 diabetes showed high rates of adverse events
[3] It is typically mild, but in rare cases it can progress to vomiting, which raises the risk of dehydration and kidney injury
data link heavy menstrual bleeding -often with fibroids- to higher rates of heart attack and stroke, even in younger women Treating fiboids has been linked to lower heart disease risk It's crucial to protect heart health with fibroids: Get regular iron checks and treat anemia earlier Monitor blood pressure and manage it with lifestyle and medication if needed Reports symptoms like palpitations and dizziness promptly The Fibroid Foundation #uterinefibroids #heart #heavymenstrualbleeding #anemia #health #worldheartday To view or add a comment, sign in 4D 3.0: Episode 1 Metabolic Syndrome and its Vicious Impact on Heart, Kidneys and Hormones: A Comprehensive Approach to Managing Obesity, Dyslipidemia and Insulin Resistance Dr
This is where BPC-157 is especially useful